Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Novartis
Johnson and Johnson
McKesson
Teva
US Army
Covington
Farmers Insurance
Healthtrust
Merck

Generated: January 21, 2018

DrugPatentWatch Database Preview

VANDAZOLE Drug Profile

« Back to Dashboard

When do Vandazole patents expire, and when can generic versions of Vandazole launch?

Vandazole is a drug marketed by Teva Pharms and is included in one NDA. There is one patent protecting this drug.

The generic ingredient in VANDAZOLE is metronidazole. There are eighteen drug master file entries for this compound. Eighty-five suppliers are listed for this compound. Additional details are available on the metronidazole profile page.
Drug patent expirations by year for VANDAZOLE
Pharmacology for VANDAZOLE
Medical Subject Heading (MeSH) Categories for VANDAZOLE

US Patents and Regulatory Information for VANDAZOLE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms VANDAZOLE metronidazole GEL;VAGINAL 021806-001 May 20, 2005 BX RX No No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Premature patent expiration for: VANDAZOLE

Expiration due to failure to pay maintenance fee

Patent Number Tradename Expiration Date
➤ Subscribe VANDAZOLE ➤ Subscribe

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
Daiichi Sankyo
Cantor Fitzgerald
Mallinckrodt
Teva
Dow
Fuji
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot